Navigation Links
USP announces new tool to help prevent medication mix-ups due to look alike/sound alike drug names
Date:8/25/2008

Rockville, Md., August 25, 2008 The U.S. Pharmacopeial (USP) Convention today announces a new drug safety tool designed to help patients, caregivers, pharmacists, physicians and others in avoiding medication errors that may occur because of drug names that look alike and/or sound alike. This "Drug Error Finder" is a searchable database of almost 1,500 commonly used drugs reported to be involved in medication mix-ups in the U.S. health care system since 2003. The database is publicly available at no cost on USP's Web site at www.usp.org/hqi/similarProducts/drugErrorFinderTool.html.

The Drug Error Finder is derived from a list of 1,470 unique drugs that were implicated in medication errors due to brand and/or generic drug names that look or sound alike and reported to USP's MEDMARXan anonymous database used by hospitals and health care systems across the United States to report, track and analyze medication errorsor to USP's Medication Errors Reporting Program. The list was included in USP's 8th annual MEDMARX Data Report, released in January 2008, which examined more than 26,000 error records related to similar drug names submitted to the database from 2003 to 2006. This is the largest known list of look alike, sound alike drug names in the world based on actual medication error reports.

"As more medications are approved for market each year and become available to Americans, the opportunity for potentially dangerous or even deadly errors due to drug mix-ups from look alike or sound alike names becomes increasingly high," said Diane Cousins, R.Ph., USP vice president of healthcare quality and information. "While one drug name may be nearly identical to that of another drug, the two could be used for completely different conditions. This presents a major public health threat, and we think this new tool can play an important role in helping to reduce patient risk associated with this problem."

One example of a drug involved in such errors reported to MEDMARX is Clonidine, a high blood pressure medication. In actual instances reported to USP, this drug was confused with multiple drugs, including Colchicine (used for gout), Cetirizine (an antihistamine), and Clonazepam and its brand name, Klonopin (used for anxiety and seizures). "As one can imagine, for someone with hypertension, receiving the wrong medication could present a potentially severe consequence," noted Cousins. "This is exactly the type of mix-up we think could be avoided through tools such as our Drug Error Finder. This may be useful to parties across the health care system who are involved in dispensing and administering medicationsand especially to caregivers and to patients, who should always remain vigilant and participate actively in their care." The 2008 MEDMARX Report found 25 different levels of individuals involved in similar name errors, from pharmacy technicians, nurses and physicians to patients and family members.

To use the Drug Error Finder, simply type in the name of the particular drug of interest. In addition to rapidly generating a list of medications that have been confused with that drug, the tool will also allow users to see the severity attributed to the reported errors involving the drug (ranging from Category A for "potential for error" to Category I for "death").

The Drug Error Finder is one component of USP's response to the Institute of Medicine's 2006 report, Preventing Medication Errors, which calls on the government and public health organizations to address medication errors resulting from similar labeling and packaging as well as confusingly similar drug names.


'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. Hartwell Medical Announces Release of CombiCarrierII Scoop Backboard to EMS Market
2. iCan Benefit Group, LLC Announces: Major Medical Division Now Offers Avalon Healthcare Products
3. NxStage Announces Presentation of Data at the American Society of Nephrologys Renal Week 2008 Annual Meeting
4. Allscripts Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
5. Corbett Accel Healthcare Group Announces Promotion of Geoff Melick to Executive Vice President, Interactive Marketing & eInnovation
6. WellPoint Announces Appointments of Lori Beer as Executive Vice President and Chief Information Officer; Martin Miller as Senior Vice President, Chief Accounting Officer and Controller
7. Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program
8. American Elements Announces Expanded Bromide and Iodide Manufacturing Capacity
9. Cylex Announces Significant Expansions and Reassignments of Personnel
10. Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
11. The Brain Aneurysm Foundation Announces 2008 Research Grant Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it will be co-hosting ... in innovative excipients and drug delivery solutions to health industries worldwide. The one ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... who administered fillers that resulted in severe facial disfiguration. After four frightening years ... by doctors at UCLA Medical Center, who removed the substances in a partial ...
(Date:1/19/2017)... ... 2017 , ... Ultimate Medical Academy (UMA) is preparing to ... making a difference in the lives of the next generation of healthcare professionals. ... educational institution, has more than 30,000 alumni and employs more than 2,000 professionals. ...
(Date:1/19/2017)... ... January 19, 2017 , ... Tribble Insurance Agency, a family owned and ... is inaugurating a charity event to honor Chad Phillip Dermyer, a local police trooper ... Chad Phillip Dermyer and his fellow officers were conducting routine stops of suspects when ...
(Date:1/19/2017)... San Mateo, CA (PRWEB) , ... January 19, ... ... now being taken in the 2017 Spring Create Real Impact contest from Impact ... through March 17 at http://www.createrealimpact.com . , Educational grants totaling $15,000 ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... 19, 2017   Science Exchange , the leading ... that the first five replication studies from the ... published in eLife today. Despite intense scrutiny around ... practical evaluation of reproducibility rates that may identify ... other assessments of reproducibility, the results of this ...
(Date:1/19/2017)... 2017 While various reports ... reducing the FDA,s regulatory strictness as a way ... drug industry, many of the leading biotech and ... and development of advanced drug treatments and therapies.  ... developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: